| 1. |
|
|
| 2. |
|
|
| 3. |
- Vithanage, M., et al.
(författare)
-
Arsenic uptake by plants and possible phytoremediation applications : A brief overview
- 2012
-
Ingår i: Environmental Chemistry Letters. - : Springer Science and Business Media LLC. - 1610-3653 .- 1610-3661. ; 10:3, s. 217-224
-
Forskningsöversikt (refereegranskat)abstract
- This review focuses the behaviour of arsenic in plant-soil and plant-water systems, arsenic-plant cell interactions, phytoremediation, and biosorption. Arsenate and arsenite uptake by plants varies in different environment conditions. An eco-friendly and low-cost method for arsenic removal from soil-water system is phytoremediation, in which living plants are used to remove arsenic from the environment or to render it less toxic. Several factors such as soil redox conditions, arsenic speciation in soils, and the presence of phosphates play a major role. Translocation factor is the important feature for categorising plants for their remediation ability. Phytoremediation techniques often do not take into account the biosorption processes of living plants and plant litter. In biosorption techniques, contaminants can be removed by a biological substrate, as a sorbent, bacteria, fungi, algae, or vascular plants surfaces based on passive binding of arsenic or other contaminants on cell wall surfaces containing special active functional groups. Evaluation of the current literature suggests that understanding molecular level processes, and kinetic aspects in phytoremediation using advanced analytical techniques are essential for designing phytoremediation technologies with improved, predictable remedial success. Hence, more efforts are needed on addressing the molecular level behaviour of arsenic in plants, kinetics of uptake, and transfer of arsenic in plants with flowing waters, remobilisation through decay, possible methylation, and volatilisation.
|
|
| 4. |
- Fuady, A, et al.
(författare)
-
Characterising and Addressing the Psychosocial Impact of Tuberculosis in Indonesia (CAPITA): A study protocol
- 2022
-
Ingår i: Wellcome open research. - : F1000 Research Ltd. - 2398-502X. ; 7, s. 42-
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Tuberculosis (TB)-related stigma remains a key barrier for people with TB to access and engage with TB services and can contribute to the development of mental illnesses. This study aims to characterise stigmatisation towards people with TB and its psychosocial impact in Indonesia. Methods: This study will apply a sequential mixed method in two main settings: TB services-based population (setting 1) and workplace-based population (setting 2). In setting 1, we will interview 770 adults with TB who undergo sensitive-drug TB treatment in seven provinces of Indonesia. The interview will use the validated TB Stigma Scale questionnaire, Patient Health Questionnaire-9, and EQ-5D-5L to assess stigma, mental illness, and quality of life. In Setting 2, we will deploy an online questionnaire to 640 adult employees in 12 public and private companies. The quantitative data will be followed by in-depth interview to TB-related stakeholders. Results: CAPITA will not only characterise the enacted stigma which are directly experienced by people with TB, but also self-stigma felt by people with TB, secondary stigma faced by their family members, and structural stigma related to the law and policy. The qualitative analyses will strengthen the quantitative findings to formulate the potential policy direction for zero TB stigma in health service facilities and workplaces. Involving all stakeholders, i.e., people with TB, healthcare workers, National Tuberculosis Program officers, The Ministry of Health Workforce, company managers, and employees, will enhance the policy formulation. The validated tool to measure TB-related stigma will also be promoted for scaling up to be implemented at the national level. Conclusions: To improve patient-centered TB control strategy policy, it is essential to characterise and address TB-related stigma and mental illness and explore the needs for psychosocial support for an effective intervention to mitigate the psychosocial impact of TB.
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Syamlan, AT, et al.
(författare)
-
Mental health and health-related quality of life among healthcare workers in Indonesia during the COVID-19 pandemic: a cross-sectional study
- 2022
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 12:4, s. e057963-
-
Tidskriftsartikel (refereegranskat)abstract
- Healthcare workers (HCWs) are the front lines during the COVID-19 pandemic. They are more exposed to COVID-19 than other professions. Studies from other countries have shown that the mental health and health-related quality of life (HRQoL) of HCWs were affected during this pandemic. However, studies on mental health in Indonesia remain scarce and no study has evaluated the HRQoL among HCWs. Thus, this study was designed to explore the mental health status and HRQoL among HCWs in Indonesia.DesignThis was a cross-sectional study.SettingThis was an open online survey in Indonesia conducted from December 2020 to February 2021.ParticipantsThis study involved HCWs who worked during the COVID-19 pandemic. Of the 502 respondents who accessed the online questionnaire, 392 were included in the analysis.OutcomesMental health status was measured using the 21-item Depression, Anxiety and Stress Scale and HRQoL was measured using the second version of the 12-item Short-Form Health Survey (SF12v2).ResultsThe prevalence of depression, anxiety and stress among HCWs was 29.4%, 44.9% and 31.8%, respectively. Using the SF12v2 questionnaire, 354 (90.3%) HCWs were found to have impaired physical component and 156 (39.8%) HCWs have impaired mental component.ConclusionThe prevalence of mental health problems among HCWs was high in Indonesia. HRQoL, particularly the physical component, was affected in most HCWs. Thus, policymakers should give more attention to the mental health and HRQoL of HCWs during the COVID-19 pandemic.
|
|
